JODY LAMBERT: Open Payments
NPI 1427308865 · ERIE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$291 in 17 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $291
Food & beverage: $291
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $80 |
| Novo Nordisk Inc | 4 | $67 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| SANOFI-AVENTIS U.S. LLC | 1 | $18 |
| Medtronic, Inc. | 1 | $16 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: UBRELVY, Ozempic, VRAYLAR, CAPLYTA, TZIELD, Wegovy, INCEPTIV, Kerendia.
Industry payments across PA — which companies pay providers there.
